Teladoc Health named Michael Grasher as chief financial officer, effective August 31, 2026, bringing more than 30 years of insurance and financial services leadership, including prior CFO roles at IFG Companies, Fortegra, and AMERISAFE. His appointment is expected to strengthen financial discipline, cost control, and capital allocation as Teladoc advances product and margin improvements, while replacing interim CFO Charles Divita, III amid ongoing revenue and margin challenges.